BAC
BAC's valuation is somewhat elevated, fundamentals are above averages and forward estimates point to earnings growth and improving margins.
BAC vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 14x | 12x | 24% higher+24% |
| PE percentile | 85 | 50 | 71% higher+71% |
| EPS | $4.34 | $3.14 | 38% higher+38% |
| FCF | $94.7B | $14.3B | 561% higher+561% |
| Loading historical comparisons… | |||
BAC’s earnings and cash flow are above their historical averages, while its earnings multiple is higher.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | Improving |
| Forward earnings | Growth |
| Forward revenue | Strong decline |
| Forward profitability | Strongly expanding |
| Analyst coverage | Moderate |
| Estimate dispersion | Tight |
BAC’s outlook is generally improving, with declining sales expectations a concern.
BAC PE Valuation
This table applies BAC's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
BAC Earnings Per Share
This chart tracks BAC's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
BAC Quarterly Revenue
This chart tracks BAC's quarterly revenue over time and shows how sales are changing from year to year.
BAC Free Cash Flow
This chart tracks BAC's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
BAC Total Shares
This chart tracks changes in BAC's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
BAC Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
BAC PE vs Financial Services Sector
This chart compares BAC's price-to-earnings (PE) ratio with the Financial Services sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
BAC Weekly Price
This chart uses BAC's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
BAC Weekly Moving Averages
This chart compares BAC's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
BAC Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.
BMA
BMA's valuation appears fair, fundamentals are below averages, while forward estimates point to improving growth and profitability, though analyst coverage is limited.
BMA vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 17x | 4.3x | 287% higher+287% |
| PE percentile | 91 | 50 | 82% higher+82% |
| EPS | $4.67 | $17.66 | 74% lower-74% |
| FCF | $1.2B | $2.4B | 51% lower-51% |
| Loading historical comparisons… | |||
BMA’s earnings and cash flow are below their historical averages, while its earnings multiple is higher.
BMA Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | Strongly improving |
| Forward earnings | Strong growth |
| Forward revenue | Strong growth |
| Forward profitability | Strongly expanding |
| Analyst coverage | Limited |
| Estimate dispersion | Moderate |
BMA’s outlook is generally improving, though analyst coverage is limited.
BMA PE Valuation
This table applies BMA's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
BMA Earnings Per Share
This chart tracks BMA's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
BMA Quarterly Revenue
This chart tracks BMA's quarterly revenue over time and shows how sales are changing from year to year.
BMA Free Cash Flow
This chart tracks BMA's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
BMA Total Shares
This chart tracks changes in BMA's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
BMA Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
BMA PE vs Financial Services Sector
This chart compares BMA's price-to-earnings (PE) ratio with the Financial Services sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
BMA Weekly Price
This chart uses BMA's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
BMA Weekly Moving Averages
This chart compares BMA's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
BMA Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.